AIM: To explore the clinical presentation, course, treatment and impact of early treatment in patients with remethylation disorders from the European Network and Registry for Homocystinurias and Methylation Defects (E-HOD) international web-based registry. RESULTS: This review comprises 238 patients (cobalamin C defect n = 161; methylenetetrahydrofolate reductase deficiency n = 50; cobalamin G defect n = 11; cobalamin E defect n = 10; cobalamin D defect n = 5; and cobalamin J defect n = 1) from 47 centres for whom the E-HOD registry includes, as a minimum, data on medical history and enrolment visit. The duration of observation was 127 patient years. In 181 clinically diagnosed patients, the median age at presentation was 30 days...
BACKGROUND: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
BACKGROUND: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
Background: The cobalamin E (cblE) (MTRR, methionine synthase reductase) and cobalamin G (cblG) (MTR...
AIM: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
AIM: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
To explore the clinical presentation, course, treatment and impact of early treatment in patients wi...
To explore the clinical presentation, course, treatment and impact of early treatment in patients wi...
Aim: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
Aim: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
AIM: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
© 2018 SSIEMAim: To explore the clinical presentation, course, treatment and impact of early treatme...
Background: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
PMC Free: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203859/Background: Remethylation defects...
PMC Free: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203859/Background: Remethylation defects...
Background: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
BACKGROUND: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
BACKGROUND: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
Background: The cobalamin E (cblE) (MTRR, methionine synthase reductase) and cobalamin G (cblG) (MTR...
AIM: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
AIM: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
To explore the clinical presentation, course, treatment and impact of early treatment in patients wi...
To explore the clinical presentation, course, treatment and impact of early treatment in patients wi...
Aim: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
Aim: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
AIM: To explore the clinical presentation, course, treatment and impact of early treatment in patien...
© 2018 SSIEMAim: To explore the clinical presentation, course, treatment and impact of early treatme...
Background: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
PMC Free: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203859/Background: Remethylation defects...
PMC Free: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203859/Background: Remethylation defects...
Background: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
BACKGROUND: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
BACKGROUND: Remethylation defects are rare inherited disorders in which impaired remethylation of ho...
Background: The cobalamin E (cblE) (MTRR, methionine synthase reductase) and cobalamin G (cblG) (MTR...